-
FRESENIUS KABI
- ATTACHEE SCIENTIFIQUE
Fresnes
2014 - maintenant
-
FRESENIUS KABI
- ATTACHEE SCIENTIFIQUE
Fresnes
2014 - maintenant
-
QUINTILES (CRO)
- Clinical Research Coordinator
2005 - 2005
SANOFI-AVENTIS - Antibiotherapy, Phase IV - Study management, home-based position
-
BAXTER
- Medical & Clinical sales rep
2005 - 2012
Clinical & Medical liaison, Anesthesiology - Anesthesiology - Operating room environment
Inhaled drugs, surgical medical devices, 1st national growth (2010) - South-West of France
-
QUINTILES (CRO)
- Clinical Research Coordinator
2005 - 2005
SANOFI-AVENTIS - Antibiotherapy, Phase IV - Study management, home-based position
-
BAXTER
- Medical & Clinical sales rep
2005 - 2012
Clinical & Medical liaison, Anesthesiology - Anesthesiology - Operating room environment
Inhaled drugs, surgical medical devices, 1st national growth (2010) - South-West of France
-
LUNDBECK Pharma
- Clinical Research Coordinator
2004 - 2004
(fixed term contract)
Psychiatry, Phase IV - Study management, home-based position
-
LUNDBECK Pharma
- Clinical Research Coordinator
2004 - 2004
(fixed term contract)
Psychiatry, Phase IV - Study management, home-based position
-
Abbott Laboratories
- Medical & Clinical sales rep
Rungis
2000 - 2002
Infusion & single-use medical devices sales - Pain area - South-West area of France
-
Abbott Laboratories
- Medical & Clinical sales rep
Rungis
2000 - 2002
Infusion & single-use medical devices sales - Pain area - South-West area of France
-
TELEFLEX
- DELEGUE HOSPITALIER
1999 - 2000
Anesthesiology & Urology - Medical devices sales (single use) - South-West of France
-
TELEFLEX
- DELEGUE HOSPITALIER
1999 - 2000
Anesthesiology & Urology - Medical devices sales (single use) - South-West of France
-
KENDLE (CRO)
- Clinical Research Associate
1993 - 1999
* (FNLCC) National League Against Cancer, Oncology, Phase III-studies (PACS) ;
* 3M SANTE, Pneumology, Phase III - NOVARTIS Pharma, Cardiology, Phase IV ;
* UCB Pharma, Allergology, Immunology, Phase II- III studies ;
* ROUSSEL UCLAF Neurobiology Phase III & Antibiotherapy, Phase II ;
* RHONE POULENC RORER, Allergology, Phase III
-
KENDLE (CRO)
- Clinical Research Associate
1993 - 1999
* (FNLCC) National League Against Cancer, Oncology, Phase III-studies (PACS) ;
* 3M SANTE, Pneumology, Phase III - NOVARTIS Pharma, Cardiology, Phase IV ;
* UCB Pharma, Allergology, Immunology, Phase II- III studies ;
* ROUSSEL UCLAF Neurobiology Phase III & Antibiotherapy, Phase II ;
* RHONE POULENC RORER, Allergology, Phase III
